AAAAAA

   
Results: 1-10 |
Results: 10
Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma
Authors: Bellone, M Cantarella, D Castiglioni, P Crosti, MC Ronchetti, A Moro, M Garancini, MP Casorati, G Dellabona, P
Citation: M. Bellone et al., Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma, J IMMUNOL, 165(5), 2000, pp. 2651-2656
Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity
Authors: Martin-Fontecha, A Moro, M Crosti, MC Veglia, F Casorati, G Dellabona, P
Citation: A. Martin-fontecha et al., Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 (CD80) and B7-2 (CD86) discloses the dominant effect of B7-1 in the induction of antitumor immunity, J IMMUNOL, 164(2), 2000, pp. 698-704
Neonatal invariant V alpha 24(+) NKT lymphocytes are activated memory cells
Authors: D'Andrea, A Goux, D De Lalla, C Koezuka, Y Montagna, D Moretta, A Dellabona, P Casorati, G Abrignani, S
Citation: A. D'Andrea et al., Neonatal invariant V alpha 24(+) NKT lymphocytes are activated memory cells, EUR J IMMUN, 30(6), 2000, pp. 1544-1550
CD28 and LFA-1 contribute to cyclosporin A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways
Authors: Geginat, J Clissi, B Moro, M Dellabona, P Bender, JR Pardi, R
Citation: J. Geginat et al., CD28 and LFA-1 contribute to cyclosporin A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways, EUR J IMMUN, 30(4), 2000, pp. 1136-1144
Vascular attack and immunotherapy: a 'two hits' approach to improve biological treatment of cancer
Authors: Dellabona, P Moro, M Crosti, MC Casorati, G Corti, A
Citation: P. Dellabona et al., Vascular attack and immunotherapy: a 'two hits' approach to improve biological treatment of cancer, GENE THER, 6(2), 1999, pp. 153-154
T-cell clonality in immune responses
Authors: Maini, MK Casorati, G Dellabona, P Wack, A Beverley, PCL
Citation: Mk. Maini et al., T-cell clonality in immune responses, IMMUNOL TOD, 20(6), 1999, pp. 262-266
NK cell triggering by the human costimulatory molecules CD80 and CD86
Authors: Wilson, JL Charo, J Martin-Fontecha, A Dellabona, P Casorati, G Chambers, BJ Kiessling, R Bejarano, MT Ljunggren, HG
Citation: Jl. Wilson et al., NK cell triggering by the human costimulatory molecules CD80 and CD86, J IMMUNOL, 163(8), 1999, pp. 4207-4212
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11
Authors: Manici, S Sturniolo, T Imro, MA Hammer, J Sinigaglia, F Noppen, C Spagnoli, G Mazzi, B Bellone, M Dellabona, P Protti, MP
Citation: S. Manici et al., Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11, J EXP MED, 189(5), 1999, pp. 871-876
Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models
Authors: Gasparri, A Moro, M Curnis, F Sacchi, A Pagano, S Veglia, F Casorati, G Siccardi, AG Dellabona, P Corti, A
Citation: A. Gasparri et al., Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models, CANCER RES, 59(12), 1999, pp. 2917-2923
Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules
Authors: Moro, M Gasparri, AM Pagano, S Bellone, M Tornaghi, P Veglia, F Corti, A Casorati, G Dellabona, P
Citation: M. Moro et al., Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules, CANCER RES, 59(11), 1999, pp. 2650-2656
Risultati: 1-10 |